Tempest Therapeutics
TPST
TPST
30 hedge funds and large institutions have $8.5M invested in Tempest Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
30
Holding in Top 10
–
Calls
$130K
Puts
$32K
Top Buyers
| 1 | +$1.45M | |
| 2 | +$600K | |
| 3 | +$441K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$229K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$172K |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$1.98M | |
| 3 | -$715K | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$578K |
| 5 |
Barclays
London,
United Kingdom
|
-$503K |